Dr. David Furman is an academic entrepreneur dedicated to solving complex problems in human biology, systems medicine, translational immunology, preventative healthcare, aging and precision longevity. As the Head of the Stanford 1000 Immunomes Project at the Stanford School of Medicine and Associate Professor and Director of the Bioinformatics and Data Science Core at the Buck Institute for Research on Aging, Dr. Furman’s research portfolio involves the use of multi-scale biology (‘omics’) technological platforms and advanced AI/ML to identify biomarkers and integrative biological clocks that can be used to track the health of an individual and pinpoint intervention strategies. In addition, his contributions on the identification of ‘exposomic’ factors, including social, lifestyle and nutritional drivers of dysfunction during aging, have opened new avenues for disease prevention and extension of human healthspan.
Novel technologies developed by the Furman lab are now able to utilize these descriptive and mechanistic biomarkers of diseases to identify and find solutions to reverse and prevent accelerated aging phenotypes and disease conditions. With over 15 years of experience in the field of systemic inflammation, as it relates to accelerated biological aging mechanisms, Dr. Furman’s innovations have impacted the field of longevity with applications in multiple fields such as brain function and mental health, age-related decline in intrinsic capacity and frailty, cardiovascular health, metabolic disease and immune system function.
As part of Dr. Furman’s entrepreneurial endeavors, he founded the Inflammaging Institute (inflammaging.org), to democratize the diagnosis of biological aging and better define detrimental exposomic factors; his Stanford spin-off, Edifice Health Inc. (Palo Alto, CA), focused on commercializing a new metric for Systemic Chronic Inflammation called “Inflammatory Age”; and his Buck Institute spin-off, Cosmica Biosciences Inc. (South San Francisco), which uses state-of-the-art simulated microgravity technologies to accelerate aging from human specimens and screen for aging-reversing drugs and natural compounds with applications in precision longevity.
Dr. Furman has published over 50 scientific articles in top-tier journals such as Cell, Nature Medicine, PNAS, The Lancet, and others, with more than 10,000 citations and is the inventor of 25+ patents.